Predicting clinical outcomes in chronic hepatitis B patients receiving nucleoside analogues and pegylated interferon alpha: a hematochemical and clinical analysis
This study provided predictive formulas for clinical cure, offering valuable insights for CHB treatment. PegIFN and NAs exhibited efficacy. Future research that explores additional factors, such as HBV genotype, in a larger cohort study is needed.
Authors
- Yanghe Wu
- Shuang Xu (ORCID: https://orcid.org/0000-0001-8071-2830)
- Dong Zhang (ORCID: https://orcid.org/0000-0001-8186-4692)
- Xiao-Ting Ye
- Pu Dong
- Chen-Wei Pan
Institutions
- Wenzhou Medical University (CN)
- Ruian People's Hospital (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2024-10-13
- DOI
- https://doi.org/10.1186/s12879-024-10057-0
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Department of Education of Zhejiang Province